9 research outputs found
PGI15 MEDICAL SERVICE UTILIZATION AND COSTS BY DISEASE SEVERITY, SUSTAINED VIRAL RESPONSE, AND GENOTYPE IN EUROPEAN PATIENTS WITH CHRONIC HEPATITIS C VIRUS
Get PDFPSS22 Cost-Effectiveness of Ranibizumab for the Treatment of Visual Impairment Due to Choroidal Neovascularization Secondary to Pathologic Myopia in the United Kingdom
Get PDFCanadian Burden Of Choroidal Neovascularization Secondary To Pathologic Myopia: Final Results
No full textRanibizumab for the Treatment of Visual Impairment Due to Myopic Choroidal Neovascularization: Cost-Effectiveness Versus Aflibercept
No full textThe Budget Impact of Introducing Ranibizumab in England and Wales for the Treatment of Visual Impairment Due to Choroidal Neovascularization Secondary to Pathologic Myopia
No full textPrevalence And Incidence Of Pathologic Myopia And Retinal Neovascularization In A US Managed Care Database
No full textPSS4 Prevalence And Incidence Of Pathologic Myopia And Retinal Neovascularization In A US Managed Care Database
Get PDF
